Notch signaling and EMT in non-small cell lung cancer: Biological significance and therapeutic application

222Citations
Citations of this article
153Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Through epithelial-mesenchymal transition (EMT), cancer cells acquire enhanced ability of migration and invasion, stem cell like characteristics and therapeutic resistance. Notch signaling regulates cell-cell connection, cell polarity and motility during organ development. Recent studies demonstrate that Notch signaling plays an important role in lung cancer initiation and cross-talks with several transcriptional factors to enhance EMT, contributing to the progression of non-small cell lung cancer (NSCLC). Correspondingly, blocking of Notch signaling inhibits NSCLC migration and tumor growth by reversing EMT. Clinical trials have showed promising effect in some cancer patients received treatment with Notch1 inhibitor. This review attempts to provide an overview of the Notch signal in NSCLC: its biological significance and therapeutic application.

Cite

CITATION STYLE

APA

Yuan, X., Wu, H., Han, N., Xu, H., Chu, Q., Yu, S., … Wu, K. (2014). Notch signaling and EMT in non-small cell lung cancer: Biological significance and therapeutic application. Journal of Hematology and Oncology, 7(1). https://doi.org/10.1186/s13045-014-0087-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free